Ministry of Health & Prevention and GlobalPharma sign agreement to maintain a strategic stock of medicines and support crisis preparedness in UAE

Ministry of Health & Prevention and GlobalPharma sign agreement to maintain a strategic stock of medicines and support crisis preparedness in UAE
10 October 2017 -
  • Ministry of Health & Prevention and GlobalPharma sign agreement to maintain a strategic stock of medicines and support crisis preparedness in UAE
    Ministry of Health & Prevention and GlobalPharma sign agreement to maintain a strategic stock of medicines and support crisis preparedness in UAE Ministry of Health & Prevention and GlobalPharma sign agreement to maintain a strategic stock of medicines and support crisis preparedness in UAE

In the well-regarded presence of HE Dr. Amin Al Amiri, Assistant Undersecretary of Public Health Plan and Licensing market at the Ministry of Health and Prevention (MOHAP), The Ministry of Health and Prevention has authorized an arrangement with GlobalPharma-- A Sanofi Company, to keep a strategic stock of medications, to be utilized in instance of crisis. The initiative is in alignment with the UAE federal government's decision to earn sure that all sectors are totally prepared to deal with emergency situations or important situations in any way times.

The finalizing ceremony was participated in by Dr. Amin Hussain Al Amiri, Assistant Undersecretary of Public Health Plan & Licensing and Dr. John Paul, Ceo of Sanofi Middle East. The finalizing was made by Dr. Abdul Karim Abdullah Al Zarouni, Director of the Department of Emergency situation, Dilemma and Calamity Workflow, from the Ministry and Karine Labaky, General Manager, Globalpharma and Middle East Head of Generics at Sanofi

Developing a sustainable healthcare setting in UAE

HE Dr. Amin stated that the key objective of the Ministry is to boost and safeguard public health by embracing innovative methods and advertising a society of proactivity and performance to safeguard optimal healthcare end results. This can be accomplished by developing superior high quality and safety systems, backed by reliable policies, solid regulations and programs that progress to satisfy the requirements of communities in UAE. Participation and assistance from industry partners like GlobalPharma aid in enhancing and sustaining the nation's health care framework.

Situation preparedness guideline and arrangement details

Dr. Amin better highlighted that an efficient inventory control version and emergency logistics systems play an essential duty in maintaining reputable circulation of vital supplies during unexpected conditions. The Ministry is proactively applying measures to make certain ample stipulation of medicines in order to supply the most effective solutions to clients and hospitals.

According to the agreement, the company will give medication stock and maintain it completely in amounts that cover the demands for one year. They will be in charge of the security of the tactical medical stock by sticking to the concepts of great storage and distribution of drugs. Even more, GlobalPharma will closely deal with The National Emergency Situation and Disaster Monitoring Authority to fulfill the terms of the contract.

Commitment and assistance to develop health care infrastructure in the UAE

Speaking on the occasion, Karine Labaky, General Manager, Globalpharma and Middle East Head of Generics at Sanofi expressed, "We are recognized to operate in cooperation with the Ministry of Health and Avoidance towards offering critical medical products that could profit people during times of crisis. GlobalPharma is dedicated to satisfying health difficulties in different methods such as owning reliable techniques for managing health care expenses, improving access to necessary medicines, sustaining local production of generics and adding to strengthening UAE's general health economic climate."

The agreement is based upon Write-up 4 of Cabinet Resolution No. (39) of 2015, which intends to supply and take care of a calculated clinical stock as part of the Ministry's clinical readiness initiatives to react to clinical and health needs whatsoever times.